PBM Effect on the Eyes
PBM has been shown to treat the following eye problems but not limited to:
-
Age-related Macular Degeneration (AMD): PBM has been proven to slow down AMD progression by protecting retinal cells and reducing inflammation. In over 90% of cases, vision can be improved following treatment.
-
Dry Eye Syndrome: PBM stimulates tear production and reduces eye surface inflammation, offering relief for dry eye symptoms.
-
Retinal Disorders: Conditions like diabetic retinopathy benefit from improved blood flow and reduced stress on the retina, helping to protect vision.
-
Optic Nerve Dysfunction: PBM could promote optic nerve regeneration, offering hope for conditions like glaucoma.
-
Retinopathy of Prematurity (ROP): PBM can have the effect of reducing long term complications from this condition which affects babies.
-
Amblyopia (Lazy eye): PBM has been proven to improve vision in lazy eyes after the visual development stage. The first treatment to ever do this!
What is Photobiomodulation?
Photobiomodulation (PBM) is a therapy that harnesses low-level light to help the body heal. Also known as low-level laser therapy or cold laser therapy, PBM is a gentle treatment that stimulates cells to repair and heal, including those in the eyes.
History of PBM
The use of light for healing dates back to the early 20th century, but it gained scientific recognition in the late 1960s and 1970s, thanks to the work of researchers like Endre Mester. Since then, studies have explored its benefits across various medical fields, including eye health.
How does PBM work?
PBM works by shining specific types of light onto areas of the body needing healing. This light gets absorbed by our cells, triggering processes that help them function better. It boosts cell energy, reduces inflammation, and improves blood flow, all of which are essential for healing.
Why is our approach Unique?
Our treatment approach stands out due to our exhaustive investigation and comparison of available research in the domain of photobiomodulation. Through this process, we have developed a method that integrates and isolates the most efficacious techniques for delivering this pioneering therapy. Our equipment is at the forefront of technological advancement, featuring uniform and homogeneous light sources. We incorporate six distinct wavelengths of light, each demonstrated to confer benefits to both intraocular and extraocular structures, thereby ensuring comprehensive stimulation of all cell types within the eye.
What are the Side Effects?
Photobiomodulation represents an advanced and safe cellular therapy.
Extensive research has not revealed any adverse effects or reactions thus far.
This underscores its versatility and the absence of documented drawbacks.
References:
1. Mester, E., Mester, A. F., & Mester, A. (1985). The biomedical effects of laser application. *Lasers in Surgery and Medicine, 5*(1), 31-39.
2. Anders, J. J., Lanzafame, R. J., & Arany, P. R. (2015). Low-level light/laser therapy versus photobiomodulation therapy. *Photomedicine and Laser Surgery, 33*(4), 183-184.
3. Hamblin, M. R. (2018). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. *AIMS Biophysics, 5*(1), 40-56.
4. Rocha, K. M., Ribeiro, M. S., & Pereira, M. C. (2017). Photobiomodulation (PBM) therapy at different wavelengths for dry eye disease: Recent advances and future perspectives. *Advances in Experimental Medicine and Biology, 1072*, 533-537.
5. Albarracin, R., Eells, J., & Valter, K. (2011). Photobiomodulation protects the retina from light-induced photoreceptor degeneration. *Investigative Ophthalmology & Visual Science, 52*(6), 3582-3592.
6. Schiffer, F., Johnston, A. L., Ravichandran, C., Polcari, A., Teicher, M. H., Webb, R. H., & Hamblin, M. R. (2009). Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. *Behavioral and Brain Functions, 5*(1), 46.
7. Arany, P. R., Cho, A., Hunt, T. D., Sidhu, G., Shin, K., Hahm, E., ... & Hamblin, M. R. (2014). Photoactivation of endogenous latent transforming growth factor–β1 directs dental stem cell differentiation for regeneration. *Science Translational Medicine, 6*(238), 238ra69.
8. Lane, N. (2006). Cell biology: power games. *Nature, 443*(7114), 901-903.
9. Huang, Y. Y., Sharma, S. K., Carroll, J., & Hamblin, M. R. (2011). Biphasic dose response in low level light therapy—an update. *Dose-Response, 9*(4), 602-618.